Regulatory mechanisms of PD-1/PD-L1 pathway on CD8+ T cell activation in murine contact hypersensitivity

被引：0
|
作者：
Hirano, T. [1 ]
Honda, T. [1 ]
Tamada, K. [2 ]
Chen, L. [3 ]
Kabashima, K. [1 ]
机构：
[1] Kyoto Univ, Dept Dermatol, Kyoto, Japan
[2] Yamaguchi Univ, Dept Immunol, Yamaguchi, Japan
[3] Yale Univ, Dept Immunobiol, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 05期
关键词：
D O I：
10.1016/j.jid.2017.02.043
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
030
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] The PD-1/PD-L1 Pathway in Human Pathology
    Saresella, M.
    Rainone, V.
    Al-Daghri, N. M.
    Clerici, M.
    Trabattoni, D.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 259 - 267
  • [22] NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
    Raffo Iraolagoitia, Ximena L.
    Spallanzani, Raul G.
    Torres, Nicolas I.
    Araya, Romina E.
    Ziblat, Andrea
    Domaica, Carolina I.
    Sierra, Jessica M.
    Nunez, Sol Y.
    Secchiari, Florencia
    Gajewski, Thomas F.
    Zwirner, Norberto W.
    Fuertes, Mercedes B.
    JOURNAL OF IMMUNOLOGY, 2016, 197 (03): : 953 - 961
  • [23] PD-1/PD-L1 Pathway in Breast Cancer
    Schuetz, Florian
    Stefanovic, Stefan
    Mayer, Luisa
    von Au, Alexandra
    Domschke, Christoph
    Sohn, Christof
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (05) : 294 - 297
  • [24] Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis
    Rodig, N
    Ryan, T
    Allen, JA
    Pang, H
    Grabie, N
    Chernova, T
    Greenfield, EA
    Liang, SC
    Sharpe, AH
    Lichtman, AH
    Freeman, GJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) : 3117 - 3126
  • [25] PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver
    Maier, Holly
    Isogawa, Masanori
    Freeman, Gordon J.
    Chisari, Francis V.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (05): : 2714 - 2720
  • [26] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [27] PD-L1/CD80 interaction differentially regulates CD8+ T cell metabolism, survival and GVHD capacity in the presence or absence of PD-1
    Cassady, Kaniel
    Song, Qingxiao
    Zhang, Yuankun
    Martin, Paul J.
    Ann, David
    Riggs, Arthur D.
    Zeng, Defu
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [28] Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
    Nowicki, Theodore S.
    Akiyama, Ryan
    Huang, Rong Rong
    Shintaku, I. Peter
    Wang, Xiaoyan
    Tumeh, Paul C.
    Singh, Arun
    Chmielowski, Bartosz
    Denny, Christopher
    Federman, Noah
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (02) : 118 - 126
  • [29] PD-L1 on radio-resistant cells negatively regulates effector CD8+ T-cell activation during the elicitation phase of contact hypersensitivity
    Hirano, T.
    Honda, T.
    Tamada, K.
    Chen, L.
    Kabashima, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S4 - S4
  • [30] PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
    Xie, Wei
    Medeiros, L. Jeffrey
    Li, Shaoying
    Tang, Guilin
    Fan, Guang
    Xu, Jie
    BIOMEDICINES, 2022, 10 (07)
12345